Associated British Foods PLC (ABF)
London Exchange · UK · prices in GBX · close of 22 Oct 2026
Key indicators
| Last close | GBX 1,932.00 |
|---|---|
| 52-week range | 1,729.45 – 2,359.00 |
| Return, 1 month / 3 months | +4.2% / −4.0% |
| Return, 1 year / 3 years | −12.4% / +10.7% |
| Trend | Uptrend |
| RSI (14) | 58 |
| Volatility (1 year) | 25.6% |
| Worst drawdown (1 year) | -22.5% |
| Average daily value traded | 1,552.38M GBX |
| Dividend yield | 3.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Associated British Foods is a British company based in London whose businesses span food and retail. Its grocery and ingredients arms make and supply sugar, cereals, bread, tea, herbs and spices, and other food ingredients to retailers, food manufacturers and foodservice customers. Its retail arm, Primark, sells low-priced clothing, footwear and accessories through stores in Britain, Ireland and continental Europe, along with the United States.
On this site Associated British Foods PLC appears as a stock on the London Exchange (UK), code ABF, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Associated British Foods PLC (ABF) trades on the London Exchange in UK. It last closed at GBX 1,932.00 on 22 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 1,060 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 12.4% and over the last three months it fell 4.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 53 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.5% | ||
| From 52-week high | -16.5% | ||
| Momentum | 42 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -4.0% | ||
| 6-month return | 5.4% | ||
| 12-month return, skipping the last month | -15.9% | ||
| Stability (higher is calmer) | 70 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 25.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.5% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 1,552.38M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 70 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 3.3% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −0.2% |
|---|---|
| 1 month | +4.2% |
| 3 months | −4.0% |
| 6 months | +5.4% |
| 1 year | −12.4% |
| 3 years | +10.7% |
| 5 years | +30.3% |
Signals
| 50-day / 200-day average | 1,931.25 / 1,904.10 |
|---|---|
| Golden / death cross (60 days) | Golden, 56 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 33.82 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 May 2026 | GBP 0.2070 |
| 11 Dec 2025 | GBP 0.4230 |
| 29 May 2025 | GBP 0.2070 |
| 12 Dec 2024 | GBP 0.6930 |
| 30 May 2024 | GBP 0.2070 |
| 14 Dec 2023 | GBP 0.4580 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.